St. Jude Medical (STJ) Reports Non Significant Data from AMPLATZER PFO Occluder RESPECT in Cryptogenic Stroke
Tweet Send to a Friend
St. Jude Medical, Inc. (NYSE: STJ) announced results from its RESPECT trial, which studied the AMPLATZER PFO Occluder in the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
